Advertisement

Shared Decision-Making and Strategies to Optimize Adherence in Older Asthmatics

  • Don Bukstein
  • Dennis K. Ledford
Chapter

Abstract

Poor adherence to asthma medication and inadequate communication are critical problems in asthma care in older adults. They contribute to morbidity and mortality through poor asthma control, frequent asthma exacerbations, acute care visits, and oral corticosteroid usage in this particularly vulnerable population. The objective of this chapter is to discuss evidence-based, time-efficient strategies that can be adopted by healthcare professionals (HCPs) to increase patient adherence and promote optimal asthma outcomes. Authors will use asthma management guidelines in older patients and other key publications to enhance discussion. Findings include that establishing patient-centered, collaborative care in older asthmatic adults facilitates effective patient–provider communication that likely will improve adherence, thus leading to improved asthma outcomes. One critical strategy is shared decision-making (SDM), in which the older adult patient and the HCP share relevant information, discuss risks versus benefits of various treatment options, express treatment preferences, deliberate the options, and agree on treatment. Asthma self-management education in older adults, which emphasizes self-efficacy, is also essential. Special attention must be paid to the health literacy of the individual as well as the cultural and social issues for each patient. In order to increase patient adherence in older asthmatic adult, clinicians need to consider a variety of factors and implement strategies directly targeting underlying issues that may be specific for older adults. Strategies may include customizing and simplifying learning and intervention regimes, identifying barriers to adherence and addressing them, ensuring patient support structures are in place, and improving self-efficacy and health literacy.

Keywords

Elderly Asthma Adherence Communication Shared decision-making Asthma self-management education 

Notes

Acknowledgments

The authors sincerely thank Sally Sochessler for her assistance and advisement.

Financial Disclosures

Dr. Bukstein declares that he has received honoraria as a speaker for AstraZeneca, Circassia, Genentech, ALK, Merck, Novartis, and Teva.

Dr. Dennis Ledford provided consultation services for AstraZeneca and Genentech; received research support paid to institution from AstraZeneca and Genentech; served as a member of speaker bureau for AstraZeneca, Boehringer Ingelheim, Genentech/Roche, Novartis, and Teva; and participated in legal reviews for cases of sudden asthma death, immunotherapy and adverse reactions, drug allergy, and indoor fungal exposure.

Funder Statement

The work for this article was not funded.

References

  1. 1.
    Vanelli M, Adler S, Vermilyea J. Moving beyond market share. In Vivo: The Business and Medicine Report. 2002;(Part 3):67–74. https://www.pharmamedtechbi.com/Publications/IN-VIVO/20/3/Moving-Beyond-Market-Share
  2. 2.
    Borrelli B, Riekert KA, Weinstein A, Rathier L. Brief motivational interviewing as a clinical strategy to promote asthma medication adherence. J Allergy Clin Immunol. 2007;120(5):1023–30.CrossRefGoogle Scholar
  3. 3.
    Bender BG. Advancing the science of adherence measurement: implications for the clinician. J Allergy Clin Immunol Pract. 2013;1(1):92–3.CrossRefGoogle Scholar
  4. 4.
    Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother. 2004;38(2):303–12.CrossRefGoogle Scholar
  5. 5.
    Bukstein D, Luskin AT, Farrar JR. The reality of adherence to rhinitis treatment: identifying and overcoming the barriers. Allergy Asthma Proc. 2011;32(4):265–71.CrossRefGoogle Scholar
  6. 6.
    Bender BG. Promoting adherence and effective self-management in patients with asthma. In: Leung DY, Szefler SJ, Bonilla FA, Akdis CA, Sampson H, editors. Pediatric allergy: principles and practice. 3rd ed. Edinburgh: Elsevier; 2016. p. 354–359.e352.CrossRefGoogle Scholar
  7. 7.
    Bender B, Milgrom H, Rand C, Ackerson L. Psychological factors associated with medication nonadherence in asthmatic children. J Asthma. 1998;35(4):347–53.CrossRefGoogle Scholar
  8. 8.
    Little P, Everitt H, Williamson I, et al. Preferences of patients for patient centred approach to consultation in primary care: observational study. BMJ. 2001;322(7284):468–72.CrossRefGoogle Scholar
  9. 9.
    McKinstry B. Do patients wish to be involved in decision making in the consultation? A cross sectional survey with video vignettes. BMJ. 2000;321(7265):867–71.CrossRefGoogle Scholar
  10. 10.
    Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002;288(19):2469–75.CrossRefGoogle Scholar
  11. 11.
    Wilson SR, Strub P, Buist AS, et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med. 2010;181(6):566–77.CrossRefGoogle Scholar
  12. 12.
    Rivera-Spoljaric K, Halley M, Wilson SR. Shared clinician-patient decision-making about treatment of pediatric asthma: what do we know and how can we use it? Curr Opin Allergy Clin Immunol. 2014;14(2):161–7.CrossRefGoogle Scholar
  13. 13.
    Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97.CrossRefGoogle Scholar
  14. 14.
    Belkora J, Volz S, Loth M, Teng A, et al. Coaching patients in the use of decision and communication aids: RE-AIM evaluation of a patient support program. BMC Health Serv Res. 2015;15:209.CrossRefGoogle Scholar
  15. 15.
    Veroff D, Marr A, Wennberg DE. Enhanced support for shared decision making reduced costs of care for patients with preference-sensitive conditions. Health Aff. 2013;32(2):285–93.CrossRefGoogle Scholar
  16. 16.
    National Asthma Education and Prevention Program. Expert panel report 3: guidelines for the diagnosis and management of asthma. Bethesda: National Heart, Lung, and Blood Institute (US); 2007.Google Scholar
  17. 17.
    Office of Disease Prevention and Health Promotion. 2020 Topics and objectives: respiratory diseases. Healthy People 2020; 2014. http://www.healthypeople.gov/2020/topics-objectives/topic/respiratory-diseases/objectives#5182
  18. 18.
    Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention; April 2015. http://www.ginasthma.org/local/uploads/files/GINA_Report_2015_Aug11.pdf
  19. 19.
    Nathan RA, Thompson PJ, Price D, et al. Taking aim at asthma around the world: global results of the asthma insight and management survey in the Asia-Pacific Region, Latin America, Europe, Canada, and the United States. J Allergy Clin Immunol Pract. 2015;3(5):734–742 e735.CrossRefGoogle Scholar
  20. 20.
    Kendrick AH, Higgs CM, Whitfield MJ, Laszlo G. Accuracy of perception of severity of asthma: patients treated in general practice. BMJ. 1993;307(6901):422–4.CrossRefGoogle Scholar
  21. 21.
    Fact sheet #1: What is health literacy? Center for Health Care Strategies, Inc; October 2013. http://www.chcs.org/media/What_is_Health_Literacy.pdf.
  22. 22.
    Quick guide to health literacy. U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. http://health.gov/communication/literacy/quickguide/Quickguide.pdf
  23. 23.
    Health literacy. National Network of Libraries of Medicine; 5 Aug 2014. http://nnlm.gov/outreach/consumer/hlthlit.html
  24. 24.
  25. 25.
    Weiss BD. Health literacy and patient safety: help patients understand. Manual for clinicians. 2nd ed. Florida State University College of Medicine. http://med.fsu.edu/userFiles/file/ahec_health_clinicians_manual.pdf. May 2007.
  26. 26.
    Bender BG. Risk taking, depression, adherence, and symptom control in adolescents and young adults with asthma. Am J Respir Crit Care Med. 2006;173(9):953–7.CrossRefGoogle Scholar
  27. 27.
    Barnes CB, Ulrik CS. Asthma and adherence to inhaled corticosteroids: current status and future perspectives. Respir Care. 2015;60(3):455–68.CrossRefGoogle Scholar
  28. 28.
    Rosenkranz MA, Busse WW, Sheridan JF, Crisafi GM, Davidson RJ. Are there neurophenotypes for asthma? Functional brain imaging of the interaction between emotion and inflammation in asthma. PLoS One. 2012;7(8):e40921.CrossRefGoogle Scholar
  29. 29.
    Thomas M, Bruton A, Moffat M, Cleland J. Asthma and psychological dysfunction. Prim Care Respir J. 2011;20(3):250–6.CrossRefGoogle Scholar
  30. 30.
    Spinhoven P, van Peski-Oosterbaan AS, Van der Does AJ, Willems LN, Sterk PJ. Association of anxiety with perception of histamine induced bronchoconstriction in patients with asthma. Thorax. 1997;52(2):149–52.CrossRefGoogle Scholar
  31. 31.
    Lavoie KL, Bacon SL, Barone S, Cartier A, Ditto B, Labrecque M. What is worse for asthma control and quality of life: depressive disorders, anxiety disorders, or both? Chest. 2006;130(4):1039–47.CrossRefGoogle Scholar
  32. 32.
    Interaction techniques. Motivational interviewing: resources for clinicians, researchers, and trainers; January 2003. http://motivationalinterview.net/clinical/interaction.html
  33. 33.
    Ratanawongsa N, Barton JL, Lyles CR, et al. Association between clinician computer use and communication with patients in safety-net clinics. JAMA Intern Med. 2016;176(1):125–8.CrossRefGoogle Scholar
  34. 34.
    Mitchell P, Wynia M, Golden R, et al. Core principles and values of effective team-based health care. National AHEC Organization; October 2012. https://www.nationalahec.org/pdfs/vsrt-team-based-care-principles-values.pdf
  35. 35.
    Hughes LD, Done J, Young A. Not 2 old 2 TXT: there is potential to use email and SMS text message healthcare reminders for rheumatology patients up to 65 years old. Health Informatics J. 2011;17(4):266–76.CrossRefGoogle Scholar
  36. 36.
    Sternfeld B, Block C, Quesenberry CP Jr, et al. Improving diet and physical activity with ALIVE: a worksite randomized trial. Am J Prev Med. 2009;36(6):475–83.CrossRefGoogle Scholar
  37. 37.
    Montes JM, Medina E, Gomez-Beneyto M, Maurino J. A short message service (SMS)-based strategy for enhancing adherence to antipsychotic medication in schizophrenia. Psychiatry Res. 2012;200(2–3):89–95.CrossRefGoogle Scholar
  38. 38.
    Stacy JN, Schwartz SM, Ershoff D, Shreve MS. Incorporating tailored interactive patient solutions using interactive voice response technology to improve statin adherence: results of a randomized clinical trial in a managed care setting. Popul Health Manag. 2009;12(5):241–54.CrossRefGoogle Scholar
  39. 39.
    Vollmer WM, Kirshner M, Peters D, et al. Use and impact of an automated telephone outreach system for asthma in a managed care setting. Am J Manag Care. 2006;12(12):725–33.PubMedGoogle Scholar
  40. 40.
    Goldman RE, Sanchez-Hernandez M, Ross-Degnan D, Piette JD, Trinacty CM, Simon SR. Developing an automated speech-recognition telephone diabetes intervention. Int J Qual Health Care. 2008;20(4):264–70.CrossRefGoogle Scholar
  41. 41.
    Bender BG, Aloia MS, Rankin AE, Wamboldt FS. Translational behavioral research in respiratory medicine. Chest. 2011;139(6):1279–84.CrossRefGoogle Scholar
  42. 42.
    Dimatteo MR. The role of effective communication with children and their families in fostering adherence to pediatric regimens. Patient Educ Couns. 2004;55(3):339–44.CrossRefGoogle Scholar
  43. 43.
    Webb SA, Litton E, Barned KL, Crozier TM. Treatment goals: health care improvement through setting and measuring patient-centred outcomes. Crit Care Resusc. 2013;15(2):143–6.PubMedGoogle Scholar
  44. 44.
    Bosworth HB, Olsen MK, Neary A, et al. Take Control of Your Blood Pressure (TCYB) study: a multifactorial tailored behavioral and educational intervention for achieving blood pressure control. Patient Educ Couns. 2008;70(3):338–47.CrossRefGoogle Scholar
  45. 45.
    Noble PC, Fuller-Lafreniere S, Meftah M, Dwyer MK. Challenges in outcome measurement: discrepancies between patient and provider definitions of success. Clin Orthop Relat Res. 2013;471(11):3437–45.CrossRefGoogle Scholar
  46. 46.
    Bloomrosen M, Sennett C. Patient engagement: challenges and opportunities for physicians. Ann Allergy Asthma Immunol. 2015;115(6):459–62.CrossRefGoogle Scholar
  47. 47.
    Coulter A, Stilwell D, Kryworuchko J, Mullen PD, Ng CJ, van der Weijden T. A systematic development process for patient decision aids. BMC Med Inform Decis Mak. 2013;13(Suppl 2):S2.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Don Bukstein
    • 1
  • Dennis K. Ledford
    • 2
  1. 1.Allergy Asthma Sinus Center, Fitchburg and MilwaukeeFitchburgUSA
  2. 2.Internal MedicineJames A. Haley VA Hospital, Tampa General Hospital, Moffitt Cancer Center, Advent HealthTampaUSA

Personalised recommendations